Cancer exports molecular 'saboteurs' to remotely disarm immune system

(University of California - San Francisco) Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have been considered untreatable are experiencing long-term remissions. Now, UC San Francisco researchers have identified a surprising phenomenon that may explain why many cancers don't respond to these drugs, and hints at new strategies to unleash the immune system against disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news